ClassID:

117781

C12Y402/02001 - CPC Classification

Classification description:

Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2) Hyaluronate lyase (4.2.2.1)

Recent Application in this class:
#1
20260027194
2026-01-29

VACCINES TARGETING C. ACNES HYALURONIDASE FOR PROPHYLAXIS AND TREATMENT OF ACNE VULGARIS

#2
20250255938
2025-08-14

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

#3
20240226243
2024-07-11

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

#4
20240207372
2024-06-27

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

#5
20240131118
2024-04-25

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

#6
20230167428
2023-06-01

A MODIFIED BACTERIAL HYALURONIDASE POLYPEPTIDE, PRODUCTION PROCESS, PHARMACEUTICAL COMPOSITIONS AND THEIR USES

#7
20220226445
2022-07-21

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

#8
20220003777
2022-01-06

Methods Employing Mucin-Specific Proteases

#9
20210330812
2021-10-28

TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY

#10
20210220446
2021-07-22

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#11
20210205420
2021-07-08

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

#12
20200030417
2020-01-30

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#13
20190194264
2019-06-27

LIPOPROTEIN EXPORT SIGNALS AND USES THEREOF

#14
20190117744
2019-04-25

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#15
20190117743
2019-04-25

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#16
20190117742
2019-04-25

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#17
20190105375
2019-04-11

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#18
20170151307
2017-06-01

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

#19
20160361437
2016-12-15

Treatment of retinal degeneration using gene therapy

#20
20150344926
2015-12-03

Enzyme Hyaluronan-Lyase, Method of Production Thereof, Use Thereof and Method of Preparation of Low-Molecular Hyaluronan

#21
20150284703
2015-10-08

Thermally stable enzymes, compositions thereof and methods of using same

#22
20140322192
2014-10-30

Proteoglycan degrading mutants for treatment of CNS

#23
20140255384
2014-09-11

Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin

#24
20110250631
2011-10-13

PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS

#25
20090041728
2009-02-12

Proteoglycan degrading mutants for the treatment of CNS

#26
20090028829
2009-01-29

Fusion proteins for the treatment of CNS

#27
20060233782
2006-10-19

Proteoglycan degrading mutants for the treatment of CNS